Takefumi Komiya

9PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 15, 2026
Incidence and Prognostic Value of TP53, STK11, and KEAP1 Mutations Between De Novo Versus Recurrent Actionable Mutation-Negative Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

|Oct 16, 2025
Novel MAML2 Fusions in Human Malignancy.

Takefumi Komiya, Kieran Sweeney, Chao H Huang

|Jan 23, 2025
Survival outcomes of surgery and adjuvant chemotherapy in early-stage small cell and large cell lung cancer: a novel focus on tumors less than 1 cm.

Jorge Raul Vazquez-Urrutia, Junjia Zhu, Shinkichi Takamori

|Sep 27, 2024
Prognostic Implications of Timing of Immunotherapy in Stage IV Non-Small Cell Lung Cancer.

Jorge Raul Vazquez-Urrutia, Max Greenberg, Junjia Zhu

|Jun 27, 2024
The Clinical Role of Adjuvant Chemotherapy after Sublobar Resection for Non-Small-Cell Lung Cancer ≤ 20 mm with Lymph Node Metastases: A Propensity-Matched Analysis of the National Cancer Database.

Shinkichi Takamori, Junjia Zhu, Asato Hashinokuchi

|Sep 30, 2022
Lymph node dissections and survival in sublobar resection of non-small cell lung cancer ≤ 20 mm.

Shinkichi Takamori, Takefumi Komiya, Mototsugu Shimokawa

Pageof 2

Frequent Collaborators

4 joint publications

Junjia Zhu

3 joint publications

Shinkichi Takamori

2 joint publications

Jorge Raul Vazquez-Urrutia

1 joint publications

Priyanka Bhatia